financetom
Business
financetom
/
Business
/
US FTC to delay decision on Chevron-Hess deal during Exxon arbitration, Bloomberg reports
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US FTC to delay decision on Chevron-Hess deal during Exxon arbitration, Bloomberg reports
Jul 11, 2024 9:51 AM

July 11 (Reuters) - The U.S. Federal Trade Commission

plans to delay its decision whether to block Chevron's ( CVX )

$53 billion takeover of Hess until after an arbitration

case with Exxon Mobil ( XOM ) is settled, Bloomberg News

reported on Thursday.

The signal from the U.S. regulator is another hurdle

for Chevron's ( CVX ) proposed acquisition of Hess. The deal, which was

initially planned to close in the first half of the year,

stalled after Exxon in March filed for arbitration, claiming a

right of first refusal over Hess' assets in Guyana.

A three-member panel has not yet begun work in a review

Exxon's claim of preemption rights to acquire Hess's Guyana

assets, the prize in the proposed merger. It is expected to set

a schedule for proceedings in the coming weeks.

Hess on June 19 said "the arbitration is moving forward

and we expect to have a decision by the end of 2024." Exxon has

signaled the arbitration process

would fall into 2025

.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Neurocrine Biosciences reports 28% jump in Q3 net sales, EPS beats estimates
Neurocrine Biosciences reports 28% jump in Q3 net sales, EPS beats estimates
Oct 28, 2025
Overview * Neurocrine Q3 2025 net product sales rise 28% yr/yr to $790 mln * Adjusted EPS for Q3 2025 beats analysts' expectations * Adjusted net income for Q3 2025 exceeds analysts' estimates Outlook * Neurocrine reaffirms full-year 2025 INGREZZA sales guidance at $2.5 bln to $2.55 bln * Company expects 2025 GAAP R&D expenses between $1 bln and $1.02...
Littelfuse to Acquire Basler Electric, Enhancing High-Growth Industrial Market Positioning
Littelfuse to Acquire Basler Electric, Enhancing High-Growth Industrial Market Positioning
Oct 28, 2025
Expands presence in mission critical, secular growth industrial markets including grid & utility infrastructure, power generation and data center Enhances high power application capabilities with a reliable and comprehensive controls and protection systems portfolio Complements industrial technology offering, resulting in a more complete solution set and broader customer access Delivers value creation through growth and operational enhancement opportunities; expected to...
Eastern Bankshares, Inc. and HarborOne Bancorp, Inc. Announce Merger to be Effective on November 1, 2025
Eastern Bankshares, Inc. and HarborOne Bancorp, Inc. Announce Merger to be Effective on November 1, 2025
Oct 28, 2025
BOSTON & BROCKTON, Mass.--(BUSINESS WIRE)-- Eastern Bankshares, Inc. ( EBC ) (“Eastern”) , the holding company for Eastern Bank, and HarborOne Bancorp, Inc. ( HONE ) (“HarborOne”) , the holding company for HarborOne Bank, today jointly announced the following: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251027195049/en/ The closing occurred today under the Agreement and Plan of...
Evolv Technologies Holdings Insider Sold Shares Worth $2,952,000, According to a Recent SEC Filing
Evolv Technologies Holdings Insider Sold Shares Worth $2,952,000, According to a Recent SEC Filing
Oct 28, 2025
04:14 PM EDT, 10/28/2025 (MT Newswires) -- Anil Chitkara, Founder & Chief Growth Officer, on October 24, 2025, sold 360,000 shares in Evolv Technologies Holdings ( EVLV ) for $2,952,000. Following the Form 4 filing with the SEC, Chitkara has control over a total of 1,275,100 Class A common shares of the company, with 1,275,100 shares held directly. SEC Filing:...
Copyright 2023-2026 - www.financetom.com All Rights Reserved